Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial - Concepedia

Concepedia

Publication | Open Access

Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial

DOI Full Paper Access

225

Citations

28

References

2016

Year

Maurizio Fava, Michael E. Thase, J. Alexander Bodkin, Madhukar H. Trivedi, Marc de Somer, Yangchun Du, Richard Leigh-Pemberton, Lauren DiPetrillo, Bernard L. Silverman, Elliot Ehrich

American Journal of Psychiatry

Abstract

The buprenorphine/samidorphan combination is a novel and promising candidate for treatment of major depressive disorder in patients who have an inadequate response to standard antidepressants.

References

	Year	Citations

Page 1